Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 1
1999 1
2003 1
2004 2
2005 2
2006 1
2008 5
2009 8
2010 9
2011 11
2012 12
2013 7
2014 9
2015 11
2016 12
2017 4
2018 8
2019 10
2020 3
2021 5
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Atherosclerosis: cell biology and lipoproteins.
Engelbertsen D, Rattik S, Björkbacka H. Engelbertsen D, et al. Among authors: bjorkbacka h. Curr Opin Lipidol. 2019 Feb;30(1):50-52. doi: 10.1097/MOL.0000000000000562. Curr Opin Lipidol. 2019. PMID: 30585935 No abstract available.
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction.
Jakobsson G, Papareddy P, Andersson H, Mulholland M, Bhongir R, Ljungcrantz I, Engelbertsen D, Björkbacka H, Nilsson J, Manea A, Herwald H, Ruiz-Meana M, Rodríguez-Sinovas A, Chew M, Schiopu A. Jakobsson G, et al. Among authors: bjorkbacka h. Crit Care. 2023 Sep 29;27(1):374. doi: 10.1186/s13054-023-04652-x. Crit Care. 2023. PMID: 37773186 Free PMC article.
Atherosclerosis: cell biology and lipoproteins.
Katra P, Björkbacka H. Katra P, et al. Among authors: bjorkbacka h. Curr Opin Lipidol. 2022 Jun 1;33(3):208-210. doi: 10.1097/MOL.0000000000000815. Curr Opin Lipidol. 2022. PMID: 35695617 No abstract available.
Innate immunity in atherosclerosis.
Björkbacka H, Nilsson J. Björkbacka H, et al. J Innate Immun. 2010;2(4):305-6. doi: 10.1159/000314770. Epub 2010 May 12. J Innate Immun. 2010. PMID: 20505313 Free article. No abstract available.
Atherosclerosis: cell biology and lipoproteins.
Björkbacka H. Björkbacka H. Curr Opin Lipidol. 2021 Feb 1;32(1):74-75. doi: 10.1097/MOL.0000000000000726. Curr Opin Lipidol. 2021. PMID: 33369577 No abstract available.
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation.
Mulholland M, Depuydt MAC, Jakobsson G, Ljungcrantz I, Grentzmann A, To F, Bengtsson E, Jaensson Gyllenbäck E, Grönberg C, Rattik S, Liberg D, Schiopu A, Björkbacka H, Kuiper J, Bot I, Slütter B, Engelbertsen D. Mulholland M, et al. Among authors: bjorkbacka h. Cardiovasc Res. 2024 May 7;120(6):581-595. doi: 10.1093/cvr/cvae046. Cardiovasc Res. 2024. PMID: 38563353 Free PMC article.
Atherosclerosis: cell biology and lipoproteins.
Bengtsson E, Björkbacka H. Bengtsson E, et al. Among authors: bjorkbacka h. Curr Opin Lipidol. 2016 Feb;27(1):94-6. doi: 10.1097/MOL.0000000000000267. Curr Opin Lipidol. 2016. PMID: 26655288 No abstract available.
Atherosclerosis: cell biology and lipoproteins.
Björkbacka H. Björkbacka H. Curr Opin Lipidol. 2011 Feb;22(1):74-5. doi: 10.1097/MOL.0b013e328342b0d3. Curr Opin Lipidol. 2011. PMID: 21233624 Review. No abstract available.
Atherosclerosis: cell biology and lipoproteins.
Björkbacka H. Björkbacka H. Curr Opin Lipidol. 2014 Aug;25(4):319-20. doi: 10.1097/MOL.0000000000000101. Curr Opin Lipidol. 2014. PMID: 25003740 No abstract available.
Atherosclerosis: cell biology and lipoproteins.
Björkbacka H. Björkbacka H. Curr Opin Lipidol. 2015 Feb;26(1):67-9. doi: 10.1097/MOL.0000000000000150. Curr Opin Lipidol. 2015. PMID: 25551805 No abstract available.
116 results